HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Rasoloson, D. Articles by Kulda, J. Search for Related Content PubMed PubMed Citation Articles by Rasoloson, D. Articles by Kulda, J. Agricola Articles by Rasoloson, D. Articles by Kulda, J.

Mechanisms of in vitro development of resistance to metronidazole in Trichomonas vaginalis

Department of Parasitology, Faculty of Science, Charles University in Prague, Vininá 7, 128 44 Prague 2, Czech Republic¹

Author for correspondence: Jaroslav Kulda. Tel: +42 0 2 2195 3206. Fax: +42 0 2 2491 9704. e-mail: kulda{at}natur.cuni.cz

Development of resistance against metronidazole and mechanisms responsible for this process were studied in a sexually transmitted pathogen of humans, Trichomonas vaginalis. Monitoring of changes in metabolism and protein expression that accompanied increasing resistance of strains derived from a common drug-susceptible parent (TV 10-02) showed the multistep character of the process. The aerobic type of resistance known to occur in isolates from patients non-responsive to treatment appeared at the earliest stage, followed by development of the anaerobic type of resistance which was accompanied by gradual loss of hydrogenosomal proteins associated with drug-activating pathways [pyruvate:ferredoxin oxidoreductase (PFOR), hydrogenase, ferredoxin]. Unexpectedly, the loss of PFOR did not result in acquisition of full anaerobic resistance, thus indicating an alternative source of electrons required for the drug activation. These data suggest involvement of the oxidative decarboxylation of malate in hydrogenosomes, catalysed by NAD⁺-dependent malic enzyme and subsequent transfer of reduced equivalents to the drug via NADH:ferredoxin oxidoreductase and ferredoxin. Accordingly, all components of this pathway were eliminated before the resistance was fully developed. Resistant Trichomonas vaginalis compensated the impaired function of hydrogenosomes by enhanced conversion of pyruvate to lactate in the cytosol. Further analysis of the two key enzymes involved in metronidazole activation by Northern blotting and assay for nascent mRNA showed that the insufficient expression of the PFOR protein results from decreased gene transcription, while down-regulation of malic enzyme is controlled at the mRNA level.

Keywords: drug resistance, hydrogenosome, pyruvate:ferredoxin oxidoreductase, ferredoxin, hydrogenosomal malic enzyme

Abbreviations: EPR, electron paramagnetic resonance; LDH, lactate dehydrogenase; ME, malic enzyme; MLC, minimal lethal concentration; NADH:FOR, NADH:ferredoxin oxidoreductase; PFOR, pyruvate:ferredoxin oxidoreductase; STK, succinyl thiokinase

This article has been cited by other articles:

				D. Pal, S. Banerjee, J. Cui, A. Schwartz, S. K. Ghosh, and J. Samuelson Giardia, Entamoeba, and Trichomonas Enzymes Activate Metronidazole (Nitroreductases) and Inactivate Metronidazole (Nitroimidazole Reductases) Antimicrob. Agents Chemother., February 1, 2009; 53(2): 458 - 464. [Abstract] [Full Text] [PDF]

				J. Muller, M. Sterk, A. Hemphill, and N. Muller Characterization of Giardia lamblia WB C6 clones resistant to nitazoxanide and to metronidazole J. Antimicrob. Chemother., August 1, 2007; 60(2): 280 - 287. [Abstract] [Full Text] [PDF]

				J. Muller, J. Wastling, S. Sanderson, N. Muller, and A. Hemphill A Novel Giardia lamblia Nitroreductase, GlNR1, Interacts with Nitazoxanide and Other Thiazolides Antimicrob. Agents Chemother., June 1, 2007; 51(6): 1979 - 1986. [Abstract] [Full Text] [PDF]

				I. Hrdy, R. Cammack, P. Stopka, J. Kulda, and J. Tachezy Alternative Pathway of Metronidazole Activation in Trichomonas vaginalis Hydrogenosomes Antimicrob. Agents Chemother., December 1, 2005; 49(12): 5033 - 5036. [Abstract] [Full Text] [PDF]

				Y. Kikuchi, N. Ohara, K. Sato, M. Yoshimura, H. Yukitake, E. Sakai, M. Shoji, M. Naito, and K. Nakayama Novel stationary-phase-upregulated protein of Porphyromonas gingivalis influences production of superoxide dismutase, thiol peroxidase and thioredoxin Microbiology, March 1, 2005; 151(3): 841 - 853. [Abstract] [Full Text] [PDF]

				G. H. Coombs, G. D. Westrop, P. Suchan, G. Puzova, R. P. Hirt, T. M. Embley, J. C. Mottram, and S. Muller The Amitochondriate Eukaryote Trichomonas vaginalis Contains a Divergent Thioredoxin-linked Peroxiredoxin Antioxidant System J. Biol. Chem., February 13, 2004; 279(7): 5249 - 5256. [Abstract] [Full Text] [PDF]

				P. Suchan, D. Vyoral, J. Petrak, R. Sut'ak, D. Rasoloson, E. Nohynkova, P. Dolezal, and J. Tachezy Incorporation of iron into Tritrichomonas foetus cell compartments reveals ferredoxin as a major iron-binding protein in hydrogenosomes Microbiology, July 1, 2003; 149(7): 1911 - 1921. [Abstract] [Full Text] [PDF]

				A. L. Crowell, K. A. Sanders-Lewis, and W. E. Secor In Vitro Metronidazole and Tinidazole Activities against Metronidazole- Resistant Strains of Trichomonas vaginalis Antimicrob. Agents Chemother., April 1, 2003; 47(4): 1407 - 1409. [Abstract] [Full Text] [PDF]